GenSight Biologics S.A.
SIGHT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€6,967 | -€8,153 | -€5,848 | -€14,258 |
| Dep. & Amort. | €172 | €466 | €1,430 | €1,521 |
| Deferred Tax | €0 | €0 | €0 | €0 |
| Stock-Based Comp. | €237 | €366 | €418 | €422 |
| Change in WC | €1,666 | €631 | €87 | €6,368 |
| Other Non-Cash | €2,215 | €879 | -€3,432 | -€2,508 |
| Operating Cash Flow | -€2,459 | -€5,592 | -€7,345 | -€8,455 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | €0 | €1 | -€1 | -€10 |
| Net Acquisitions | €0 | €0 | €0 | €0 |
| Inv. Purchases | -€53 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €0 | €0 | €13 | €0 |
| Other Inv. Act. | €0 | €4 | €0 | €66 |
| Investing Cash Flow | -€53 | €5 | €12 | €56 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€354 | -€2,153 | -€407 | €0 |
| Stock Issued | €884 | €0 | €12,622 | €0 |
| Stock Repurch. | €0 | -€10,794 | -€22 | -€99 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | -€1 | €14,573 | €12,564 | €9,550 |
| Financing Cash Flow | €529 | €1,626 | €12,135 | €9,451 |
| Forex Effect | €7 | -€297 | €38 | €62 |
| Net Chg. in Cash | -€2,194 | -€4,476 | €4,840 | €557 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €2,464 | €6,940 | €2,100 | €1,021 |
| End Cash | €270 | €2,464 | €6,940 | €557 |
| Free Cash Flow | -€2,459 | -€5,591 | -€7,346 | -€8,465 |